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Abstract 44 
The human cytomegalovirus (HCMV) US12 family consists of ten sequentially 45 
arranged genes (US12-21) with poorly characterized function. We now identify 46 
novel NK cell evasion functions for four members:  US12, US14, US18 and US20. 47 
Using a systematic multiplexed proteomics approach to quantify ~1,300 cell 48 
surface and ~7,200 whole cell proteins, we demonstrate that the US12 family 49 
selectively targets plasma membrane proteins and plays key roles in regulating 50 
NK ligands, adhesion molecules and cytokine receptors. US18 and US20 work in 51 
concert to suppress cell surface expression of the critical NKp30 ligand B7-H6 52 
thus inhibiting NK cell activation. The US12 family is therefore identified as a 53 
major new hub of immune regulation. 54 
 55 
 56 
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Introduction 57 
At 236 kb the human cytomegalovirus (HCMV) genome is the largest of any 58 
characterized human virus and is comprised of long and short unique regions (UL 59 
and US), each flanked by inverted terminal repeats. HCMV codes for around of 60 
170 canonical protein-coding genes with 39 herpesvirus ‘core’ genes 61 
concentrated in the center of the UL region (Dolan et al., 2004). The core genes 62 
mainly encode structural components of the virion and proteins required for 63 
virus DNA replication and have orthologues in the other human herpesviruses. 64 
The vast majority of the remaining HCMV genes are not essential for virus 65 
replication in vitro (Dunn et al., 2003) yet are replete with accessory functions, 66 
many of which have been implicated in suppressing host immune responses. 67 
Unusually, HCMV encodes 15 gene families of variable size that are often 68 
clustered on the genome (Davison et al., 2002, Holzerlandt et al., 2002, Chee et 69 
al., 1990, Dolan et al., 2004, Davison et al., 2003). Many of these gene families 70 
exhibit homology with cellular genes and are conserved to various extents in 71 
other primate CMVs. Consequently, these primate CMV gene families are likely to 72 
have arisen through gene capture and amplification driven by differential 73 
selective pressures in their various primate hosts over millennia (Davison et al., 74 
2013, Davison et al., 2003).  75 
The US12 gene family consists of 10 genes, designated US12 to US21, arranged 76 
sequentially in the US region and transcribed in the same orientation (Chee et al., 77 
1990, Dolan et al., 2004). The genetic arrangement of the US12 family is 78 
reminiscent of ‘accordion’ gene expansions, which are generated when a cellular 79 
or virus resistance function is placed under strong selective pressure (Filee, 80 
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2013). Such an expansion was recently exemplified experimentally using a 81 
poxvirus interferon resistance function (Elde et al., 2012). The US12 family 82 
encodes a series of 7-transmembrane spanning proteins with low-level 83 
homology to the cellular transmembrane bax-inhibitor 1 motif-containing 84 
proteins (TMBIM). While not essential for virus replication, the US12 family has 85 
been implicated in HCMV tropism, virion maturation and immune evasion (Das 86 
and Pellett, 2007, Cavaletto et al., 2015, Bronzini et al., 2012, Hai et al., 2006, 87 
Gurczynski et al., 2014, Fielding et al., 2014).   88 
NK cells play a critical role in controlling HCMV infections, and the virus invests a 89 
substantial proportion of its coding capacity to inhibit NK cell activation 90 
(Wilkinson et al., 2013). We previously observed that US18 and US20 suppress 91 
cell surface expression of the NK cell-activating ligand MICA (Fielding et al., 92 
2014) and posited that the synergistic action of US18 and US20 may be the 93 
vestige of an immune selective pressure that drove the original expansion of the 94 
US12 family. These data show that multiple US12 family members can co-95 
operate to target the same cellular protein. Therefore individual functions, as 96 
identified with single gene viral mutants, may not be readily replicated by 97 
expressing these same viral genes in isolation, i.e. these viral genes may work 98 
more efficiently in the context of HCMV productive infection.  99 
To understand the function of all US12 family genes, we undertook a systematic 100 
functional study, and demonstrate that family members in addition to US18 and 101 
US20 are NK immunevasins. Conventional biochemical investigations on US12 102 
family proteins are rendered problematic due to their extreme hydrophobicity. 103 
We therefore established multiplexed Tandem Mass Tag (TMT)-based proteomic 104 
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analyses to systematically evaluate the capacity of all US12 family genes to 105 
modulate the cellular proteome, both individually and in concert. Such an 106 
approach has been enabled by our recent development of Plasma Membrane 107 
Profiling (PMP) to identify novel cell surface targets for the HCMV latency 108 
protein UL138 (Weekes et al., 2013) and individual viral immunevasins UL141 109 
and US2 (Hsu et al., 2015). Using Quantitative Temporal Viromics (QTV), we 110 
tracked >8000 cellular and 153 viral proteins throughout the course of 111 
productive HCMV infection, building a comprehensive picture of cellular control 112 
(Weekes et al., 2014).  113 
We generated a series of HCMV deletion mutants for each of the 10 constituent 114 
US12-21 family members together with a ‘block’ mutant that removed the entire 115 
family. Through comparative analysis of ~1,300 cell surface and ~7,200 cellular 116 
proteins during infection, we discovered that this family has a profound 117 
influence not only on NK cell recognition but other key functions that impact on 118 
immunity including cellular adhesion and cytokine signalling.119 
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Results 120 
US12 family members differentially affect NK cell activation  121 
To determine whether the US12 family has a broader role in modulating NK cell 122 
responses, a series of HCMV US12 family deletion mutants were generated (10 123 
single deletion mutants and the US12-21 ‘block’ deletion). The HCMV genome 124 
was manipulated by DNA recombineering in a strain Merlin BAC that did not 125 
express RL13 and UL128 (Stanton et al., 2010). Viruses were generated by DNA 126 
transfection and the complete genomic sequence of the virus stocks was 127 
validated by deep sequencing (Table 1). In NK functional assays, the ΔUS12-21 128 
block deletion mutant induced substantially higher levels of NK cell 129 
degranulation compared to the parent HCMV with all 4 different donors tested 130 
(Fig. 1B). Significantly increased levels of NK activation were detected in assays 131 
using deletion mutants of 5 different US12 family members: US12 (3 of 4 132 
donors), US14 (1 of 4 donors, with a trend towards increased NK activation in 133 
the other 3 donors), US18 (3 of 4 donors), US20 (4 of 4 donors), US21 (4 of 4 134 
donors) (Fig. 1B), while three US12 family deletion mutants (US15, US16, US19) 135 
reduced the level of NK cell activation in some donors (Fig. 1B). Although 136 
members of the US12 family are capable individually of either activating or 137 
suppressing NK cell function, the net effect of the complete US12 gene family is 138 
clearly to inhibit NK cell recognition.  139 
The US12 family targets plasma membrane proteins 140 
To provide an unbiased systematic analysis of the entire US12 gene family, we 141 
employed 10-plex tandem-mass tags (TMT) with MS3/Multinotch mass 142 
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spectrometry to quantify whole cell (WCL) and plasma membrane (PM) 143 
proteomes in fibroblasts infected with the panel of HCMV US12 family mutants. 144 
The proteomic analyses were performed in two parts to permit inclusion of 145 
appropriate controls. Samples analyzed in Proteomic Series 1 included mock-146 
infected controls, the parental HCMV strain, the US12-21 block deletion and 147 
defined mutants in US18, US19 and US20 (Fig. 2, Fig. 3, Fig. 4A). Mass 148 
spectrometry quantified 7215 WCL and 1281 PM proteins.  The extremely 149 
dynamic modulation of the host cell proteome observed during productive 150 
HCMV infection was consistent with previous findings (Fig. 3)(Weekes et al., 151 
2014). The role of the entire US12 gene family was assessed by comparison of 152 
the HCMV US12-21 block deletion mutant with its parental virus. The impact was 153 
most noticeably focused on the PM, in that the majority of WCL proteins affected 154 
were also PM ‘hits’ (Fig. 2). The heat map illustrating changes in protein 155 
abundance correspondingly appears more dynamic i.e. a higher proportion of 156 
proteins detected were regulated in response to the deletion of individual US12 157 
family genes for the PM proteome than for the much larger set of proteins 158 
quantified in WCL samples (Fig. 3). For a given PM protein modulated by the 159 
US12 gene family (Fig. 4), comparable results were observed in WCL samples 160 
(Fig. 5), suggesting that the US12 family regulates protein expression or stability 161 
of cell surface proteins. 162 
NK cells continually monitor the levels of inhibitory and activating ligands on the 163 
surface of potential targets, thus one of the roles of the US12 family in re-164 
modeling the PM proteome is compatible with its role in directly impacting NK 165 
cell recognition. To gain an overview of pathways targeted, the online 166 
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bioinformatics resource DAVID (Database for Annotation, Visualisation and 167 
Intergrated Discovery; https://david.ncifcrf.gov/) was used to perform a KEGG 168 
(Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis on 169 
proteins rescued> 3 fold by the deletion of the US12-21 block (Dennis et al., 170 
2003, Huang da et al., 2009). Multiple KEGG pathways were significantly 171 
enriched (data not shown), including natural killer cell-mediated cytotoxicity 172 
(MICA, MICB, ULBP2, IFNGR1), cytokine-cytokine receptor interaction (IL6ST, 173 
KIT, KITLG, ACVRL1, ACVR1, IFNGR1) and cell adhesion molecules (CAMs; JAM3, 174 
ICOSLG, PTPRM, MPZL1, CXADR, ALCAM, SDC4, CD99, SDC1). The modulation of 175 
cell adhesion molecules and chemokines/cytokines may additionally impact NK 176 
cell recognition.  A further NK ligand, B7-H6, was not identified by DAVID 177 
analysis, but was also regulated by the US12-21 mutant. While MICA is a 178 
recognized target of US18 and US20 (Fielding et al., 2014), the regulation of the 179 
NK cell activating ligands B7H6, MICB and ULBP2 by the US12 family are novel.   180 
Functional independence and co-operation exerted by family members 181 
A substantial subset of the proteins regulated by the US12-21 block mutant were 182 
similarly modulated by US18 and US20 (Fig. 4, Fig. 5), whereas US19 specifically 183 
targeted RALGPS2 (Fig. 6). To determine the contribution of each individual 184 
US12 family member to the overall effects observed with the ‘block’ deletion 185 
mutant, Proteomic Series 2 compared infection with all the single gene deletion 186 
mutants (except the US19 deletion) to the parent HCMV (Fig. 4B). Mass 187 
spectrometry quantified 7156 whole cell and 1312 PM proteins. We re-examined 188 
key candidate molecules identified by bioinformatic analysis of the US12-21 189 
block deletion (Fig. 4C-E). A striking feature of this data was that the majority of 190 
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these target proteins were regulated by both US18 and US20, with a subset 191 
additionally regulated to a lesser degree by US14 and/or US16 (Fig. 4C-E). Other 192 
US12 family members also had important effects, with US12 and US13 mutants 193 
regulating the NKG2D ligands (NKG2DL) ULBP2 and MICB respectively, US14 194 
mutant regulating PTPRM, and the US15 mutant regulating IL6ST (Fig. 4C-E and 195 
Fig. 6). Overall, the contribution made by a given family member varied 196 
dramatically ranging from the highly focused impact of US13 and US19 (1 197 
cellular target each) to the exceptionally promiscuous US20 (54 cellular targets) 198 
(Fig. 6). Where a given protein was quantified both in PM and WCL samples, 199 
generally similar changes were observed in both samples (Fig. 4 & 5). 200 
Interestingly, MICA was regulated by the deletion of US12-21 block to a much 201 
greater extent than any of the single deletion mutants, implying that multiple 202 
US12 family members may need to act in concert to optimize control over certain 203 
cellular targets (Fig. 4C).  204 
Infection with the US21 deletion mutant resulted in selective impairment of 205 
many late phase Tp3 and Tp5 (Temporal protein profile 3 and 5) HCMV proteins 206 
(Weekes et al., 2014), for example UL32 and UL99/pp28, and elevated 207 
expression of pUS20, whereas the HCMV US12-21 block mutant did not 208 
recapitulate this effect (Fig. 7, with further proteomic data searchable in Excel 209 
spreadsheet Supplemental File 1).  Our data are consistent with deletion of the 210 
US21 structural gene impacting on the transcriptional control of the US20 (data 211 
not shown), and may contribute to a potential growth defect observed for this 212 
particular mutant. Therefore the activation of NK cells in response to US21 213 
mutant-infected targets cannot be assigned directly to an effect of US21 (Fig. 1). 214 
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A definitive assessment of the function of US21 will require an alternative 215 
approach.   216 
Of all PM proteins regulated >3-fold by a member of the US12-21 family, 29% 217 
were regulated by 2 or more family members and 6% by 3 or more family 218 
members (Fig. 6), although using a stringent 3-fold cutoff may underestimate the 219 
true incidence of co-regulation. Such co-regulation may suggest evolutionary 220 
pressure underpins the expansion of this gene family. 221 
Effect of lysosomal inhibition on US12 family targets 222 
The majority of proteins that the US12 family down regulates from the PM are 223 
also lost from the WCL, consistent with post-translational proteolysis or an 224 
overall reduction in expression. We previously found that US20 targets the 225 
NK2DL MICA for degradation in the lysosome (Fielding et al., 2014). The DAVID 226 
pathway analysis identified increases in lysosomal proteins within the PM 227 
fraction of ΔUS20-infected cells; the list of lysosomal proteins included a number 228 
of cathepsins and ATPases (PSAP, CTSD, ATP6V1E1, ATP6V1H, NPC2) (data not 229 
shown). These data suggest a role for US20 in regulating intracellular endo-230 
lysosomal vesicular transport. 231 
To determine if this is a more general mechanism for the whole US12-21 family, 232 
HFFs were infected with HCMV, the US12-21 block deletion mutant or HCMV in 233 
the presence of the lysosomal protease inhibitor leupeptin for 12h prior to 234 
harvest, and protein expression was analyzed by 10-plex TMT at 24h, 48h and 235 
72h post-infection (Proteomic Series 3, Fig. 8A).  236 
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The ΔUS12-21 ‘block’ deletion caused substantial shifts in WCL proteins, with 237 
>80 proteins rescued >2-fold at 48h, compared to the parent viral infection (Fig. 238 
8B). Of these, 26% were also rescued >2-fold and 51% >1.5-fold with leupeptin 239 
suggesting that the US12 family targets multiple host proteins to the lysosome. 240 
Leupeptin treatment had a more limited effect on rescuing PM proteins back to 241 
the the cell surface (Fig. 8B), consistent with our previous observation of 242 
intracellular accumulation of MICA without protein relocalisation to the cell 243 
surface during treatment with leupeptin or other lysosomal inhibitors (Fielding 244 
et al., 2014). Of the 21 proteins identified in Fig. 4 within the key categories 245 
‘natural killer cell-mediated cytotoxicity’, ‘cytokine-cytokine receptor 246 
interaction’ and ‘cell adhesion molecules’, 11 were rescued >2-fold by leupeptin, 247 
with the remainder exhibiting 1.3-2-fold rescue (Fig. 8C). MICB was clearly 248 
rescued by leupeptin treatment (Fig. 8C). Interestingly, control of MICB and 249 
ULBP2 levels correlated with regulation of UL16 by US13 and US12 (Fig. 9).  250 
However, leupeptin rescue of ULBP2 and UL16 was less convincing than for 251 
MICB (Fig. 9).  Although many cellular substrates of the US12 family are clearly 252 
being targeted for lysosomal degradation, there may be additional mechanisms 253 
by which this family regulates the PM proteome.  254 
Validation of PM protein regulation by US12 family members 255 
We used flow cytometry to validate a proportion of the various PM protein 256 
targets that are regulated by the US12 family (Fig. 10). Next, we examined 257 
NKG2DL MICA and MICB (Fig. 10). We found that MICA expression was rescued 258 
to a greater degree with the US12-21 block mutant than with the individual US18 259 
or 20 deletion mutants (Fig. 10). This is consistent with our previous analysis 260 
 13
showing that a combined US18 and US20 deletion had a greater effect on cell 261 
surface MICA than single gene deletion mutants (Fielding et al., 2014). The US13 262 
deletion mutant caused a minor, but consistent, elevation in cell surface 263 
expression of MICB. Other US12 family genes may yet contribute to regulating 264 
MICB, as there was a further increase in the US12-21 block mutant (Figs. 10, 4C).   265 
B7-H6 is an NK cell activating ligand targeted by US18 and US20 266 
The fact that, in addition to targeting MICA, US18 and US20 together are also 267 
implicated in targeting B7-H6 is extraordinary. B7-H6 is a known ligand for 268 
NKp30 and exogenous expression in fibroblasts increased NK degranulation (Fig. 269 
11A-C). Ectopic expression of US20, and to a lesser extent US18, from adenovirus 270 
vectors reduced levels of exogenously expressed B7-H6 detected by 271 
immunoblotting (Fig. 11D). Both PM and WCL expression of B7-H6 was induced 272 
by the HCMV US18, US20 and US12-21 deletion mutants but not by the parental 273 
virus (Figs. 4C, Fig. 5A), which was confirmed by flow cytometry and 274 
immunoblot (Fig. 10 and 12A). B7-H6 is therefore induced as a ‘stress ligand’ 275 
during productive infection, but its expression is controlled by US18 and US20, 276 
acting in concert, to target it for proteolysis (Fig. 8C). Being the dominant ligand 277 
for the NK activating receptor NKp30, B7-H6 is potentially a critical target for 278 
HCMV. 279 
We investigated the effect of the US12 family members upon activation of an 280 
NKp30-responsive reporter cell line, and found that the presence of US18 and 281 
US20 was required to inhibit reporter activity (Fig. 12B). Reporter cell 282 
fluorescence could be inhibited either by transfection of B7-H6 specific siRNA or 283 
by use of a B7-H6 specific blocking antibody (CH31) (Figs. 12C & 12D 284 
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respectively).  The presence of both US18 and US20 was required to prevent B7-285 
H6 activating the NKp30 reporter function.  286 
We sought to differentiate the functional impact exerted by US18 and US20 on 287 
B7-H6 and MICA.  B7-H6 knockdown in cells infected with HCMV US18 and US20 288 
deletion mutants was correspondingly able to reduce donor NK cell activation 289 
(Figs. 13A & 13B). The impact of B7-H6 knockdown on the HCMV US12-21 block 290 
mutant was more variable and consistent with the US12 gene family encoding 291 
additional NK modulating functions (Fig. 13B, Fig. 1). A B7-H6 blocking antibody 292 
had an even more pronounced effect, reducing NK activation in response to the 293 
US18, US20 and US12-21 deletion mutants to levels of the parental HCMV control 294 
(Fig. 13C). These results are consistent with B7-H6 playing a major role in NK 295 
cell recognition of HCMV-infected cells, a function that is countered by the US12 296 
family members US18 and US20.  297 
Discussion 298 
The HCMV genome contains 15 gene families of various sizes that have been 299 
acquired during evolution to promote virus persistence. Clusters of US12-related 300 
genes can be detected in cytomegaloviruses of New World primates, i.e. Green 301 
Monkey and Owl Monkey CMVs, thus the capture and expansion of an ancestral 302 
precursor presumably took place over 41 million years ago (Davison et al., 303 
2013). Within Cynomolgus and Rhesus macaques (Old World primates), 304 
chimpanzee and human CMVs, the US12 family is maintained as a well conserved 305 
contiguous tandem array of 10-11 genes located in the same relative position on 306 
each genome. Amongst circulating HCMV clinical strains, the US12 family 307 
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exhibits relatively high levels of sequence conservation and genetic integrity 308 
(Sijmons et al., 2015).  309 
The complexity of the HCMV genome, its restricted host range in vitro and 310 
protracted replication cycle has frustrated studies into HCMV gene function. 311 
However, the advent of high-resolution multiplexed proteomics is 312 
revolutionizing our understanding of how HCMV orchestrates host cell gene 313 
expression and evades host defenses (Weekes et al., 2014, Hsu et al., 2015). By 314 
systematically analyzing a bespoke panel of HCMV deletion mutants, we have 315 
discovered that the US12 family selectively targets a broad range of plasma 316 
membrane proteins that include, not only NK cell activating ligands, but also T-317 
cell co-stimulatory molecules, cell adhesion molecules, and cytokine/cytokine 318 
receptors. The diversity of proteins targeted by many of the US12 family implies 319 
a broad strategy of redirecting cell surface receptors. A sizeable proportion of 320 
targeted plasma membrane proteins do not accumulate internally, but are 321 
degraded in lysosomes, as indicated by rescue with the inhibitor leupeptin. The 322 
overlap that exists between US12 gene family targets with those of the KSHV K5 323 
viral E3 ubiquitin ligase (MICA, MICB, B7 family, ALCAM, IFNGR1, PTPRM, 324 
EPHA2, CD99, MPZL1/2) could represent convergent evolution and/or targeting 325 
of similar cellular pathways (Timms et al., 2013).  326 
The US12 family has a major impact on NK cell recognition with four US12 family 327 
members US12, US14, US18 and US20 consistently contributing toward 328 
significant levels of NK cell protection. Although the HCMV US21 deletion mutant 329 
also scored in functional assays, this is likely due to enhanced expression of 330 
pUS20 associated with this construct. The NKG2DL MICB and ULBP2 are strongly 331 
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upregulated during HCMV infection, but fail to reach the cell surface as they are 332 
retained in the ER by the NK evasion function gpUL16 (Rolle et al., 2003). Our 333 
proteomic data reveal that deletion of US12, US13 and US20 leads to increased 334 
cell surface and intracellular expression of MICB, ULBP2 and UL16 itself (Fig. 9). 335 
These observations are consistent with US12 family members acting in concert 336 
to direct UL16, MICB and ULBP2 towards proteolytic degradation, with leupeptin 337 
treatment clearly able to rescue MICB, and this may contribute to the NK evasion 338 
properties of US12 (Fig 1). They also imply that some of the effects of the US12 339 
family could be the result of co-operation with other HCMV genes. There is some 340 
precedent for this situation, although not previously on such a wide scale,  as co-341 
operation between US2 and UL141 was observed in the proteasomal 342 
degradation of some protein targets e.g. CD112 (Hsu et al., 2015). None of the 343 
US14 targets are recognized NK cell ligands, suggesting that this gene product 344 
utilizes a novel NK evasion mechanism. 345 
 B7-H6 is the major ligand identified for the natural cytotoxicity receptor (NCR) 346 
NKp30 and a tumor antigen (Brandt et al., 2009). Previously, B7-H6 expression 347 
was shown to be induced by inflammatory stimuli, for example pro-348 
inflammatory cytokines and bacterial-derived toll-like receptor (TLR) ligands 349 
(Matta et al., 2013).  We show here that B7-H6 expression is induced as a stress 350 
protein by HCMV infection (and potentially other virus infections) and that US18 351 
and US20 act together to suppress cell surface expression of B7-H6 in the context 352 
of HCMV, thereby inhibiting NK cell activation. US18 and US20 were also able to 353 
regulate exogenously expressed B7-H6 when expressed individually. Therefore, 354 
they appear to target B7-H6 directly and not cellular pathways leading to the 355 
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expression of B7-H6. The control of B7-H6 is likely to be of major significance as 356 
NKp30 is expressed on γδ T-cells (Vδ2-) that are induced during HCMV infection 357 
post-transplantation and correlate with control of disease (Merville et al., 2000, 358 
Lafarge et al., 2001, Correia et al., 2011).  359 
The US12 family clearly impacts on a broad range of cellular functions including 360 
adhesion molecules and cytokine receptors.  Many of these adhesion molecules 361 
play roles in co-stimulation or immune synapse formation of T-cells e.g. ALCAM, 362 
ICOSLG, CXADR (Hassan et al., 2004, Wang et al., 2000, Witherden et al., 2010). 363 
The US12 family targets pro-inflammatory mediators, such as multiple members 364 
of the tumour necrosis factor receptor (TNFR) superfamily (TNFRSF8, 365 
TNFRSF12A, NGFR, LTBR), gp130 (IL6ST), the IL-6 receptor signaling receptor, 366 
pannexin-1 (PANX1) and the TLR4 ligand high-mobility group protein B1 367 
(HMGB1) (Croft et al., 2013, Kanneganti et al., 2007, Park et al., 2004). IL6ST 368 
signaling may also have antiviral effects in the context of HCMV (Harwardt et al., 369 
2016), which was suggested by the finding that disruption of gp130 STAT3 370 
binding resulted in IFN-like signaling through STAT1(Costa-Pereira et al., 2002). 371 
The closest cellular homologues to the US12 family are the TMBIM family with 372 
recognised functions in controlling apoptosis, ER stress, ROS production, actin 373 
production, glucose metabolism and protein trafficking (Rojas-Rivera and Hetz, 374 
2015). The US12 family may have arisen through an ‘accordion’ gene expansion 375 
from a ‘captured’ ancestor TMBIM gene. Out of the entire US12 family, US21 376 
displays the highest level of homology with TMBIM1/4, with the homologous 377 
region limited to the transmembrane domain and loops (unpublished 378 
observations, (Lesniewski et al., 2006, Holzerlandt et al., 2002)). The divergence 379 
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of the US12 and TMBIM families is also reflected in their different membrane 380 
topologies, as TMBIM family have cytosolic N- and C-termini with 6 full 381 
transmembrane spanning regions, and US20 has a cytosolic N-terminus and 382 
lumenal C-terminus (Carrara et al., 2012, Cavaletto et al., 2015). The functional 383 
relevance of the US12 family/TMBIM homology remains unclear, although it may 384 
represent a ‘functional scaffold’ (Lesniewski et al., 2006), as a number of TMBIMs 385 
also target proteins for lysosomal degradation (Lee et al., 2012, Yamaji et al., 386 
2010). 387 
Our data indicate that the US12 family targets multiple host immune ligands, 388 
consistent with the family having arisen, been selected and diverged in function 389 
as a consequence of immune selection. US12 family genes differ from the 390 
majority of characterised immune evasion viral genes, as they act together and 391 
do not exhibit single gene effects. The targeting of multiple proteins by a HCMV 392 
immunevasin or co-operation between HCMV gene products is not 393 
unprecedented, but was not previously observed on this scale or with this 394 
diversity of target proteins (Tomasec et al., 2005, Prod'homme et al., 2010, Smith 395 
et al., 2013, Hsu et al., 2015). The majority of US12 family targets contain an 396 
immunoglobulin-like domain, including the MHC I-related proteins, MICA and 397 
B7-H6. While NKp30 and B7-H6 homologues are present in many vertebrate 398 
species, including Xenopus, where NKp30 may be a forerunner of antigen-specific 399 
receptors, NKG2DL and NKG2D are present in placental and marsupial mammals 400 
(Flajnik et al., 2012, Kasahara and Yoshida, 2012). Our data highlight the 401 
importance that HCMV gene families are likely to play in terms of HCMV 402 
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persistence in vivo and identifies the US12 family as a critical region for 403 
regulation of the host immune response. 404 
Materials and Methods 405 
Ethics statement 406 
Healthy adult volunteers provided blood for this study following written 407 
informed consent (approved by the Cardiff University School of Medicine Ethics 408 
Committee Ref. no: 10/20) or buffy coats provided by the Welsh Blood Service, 409 
following informed consent. 410 
Cell lines 411 
Human foreskin fibroblasts (HFFs), HFFs immortalized by human telomerase 412 
(HF-TERT), HF-TERTs transfected with the Coxsackie-adenovirus receptor (HF-413 
CAR), were maintained at 37°C in 5% CO2 in growth medium (Dulbecco’s 414 
minimal essential medium (DMEM) supplemented with penicillin/streptomycin 415 
and 10% fetal calf serum (Invitrogen, Paisley, UK) (McSharry et al., 2001). 416 
Viruses 417 
HCMV deletion mutants were generated by recombineering of the bacterial 418 
artificial chromosome (BAC) of HCMV strain Merlin (GenBank accession number 419 
GU179001.1), as described previously (Stanton et al., 2010). Strain Merlin 420 
contains the complete genetic complement of HCMV, and is frame shifted in two 421 
genes (RL13–, UL128–). Alterations to the BAC were monitored by local PCR and 422 
Sanger sequencing, and the entire genomes of the viruses were confirmed by 423 
Illumina sequencing as described previously (Murrell et al., 2016). Details of the 424 
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viruses are provided in Table 1 and a list of primers used in their construction 425 
and local sequencing of the BACs are provided in Tables 2 and 3 respectively. 426 
Primers used in the construction of the HCMV ΔUS18 and ΔUS20 deletion 427 
mutants were detailed previously (Fielding et al., 2014).  428 
The replication-deficient adenovirus vector (RAd-CTRL, pAL1253) and 429 
adenovirus vectors expressing US18 (RAd-US18) and US20 (RAd-US20) from the 430 
Merlin strain of HCMV have been described previously (Fielding et al., 2014). A 431 
B7-H6 (NCR3LG1) expressing adenovirus was generated by synthesising the B7-432 
H6 CDS (corresponding to Accession number NM_001202439.2, bases 209-1573 433 
retaining the stop codon) with 5’ and 3’ arms of homology to the AdZ BAC 434 
(corresponding to the For and Rev primers used in the AdZ recombineering 435 
protocol) (Stanton et al., 2008) and flanking EcoRI sites (gene synthesis from 436 
Genscript). The cassette containing the B7-H6 CDS and both arms of homology 437 
was released from the pUC57 vector by EcoRI digest, gel purified and inserted 438 
into pAL1141 by recombineering to produce pAL1593. BAC DNA of pAL1593 439 
purified by maxiprep (Macherey-Nagel) was transfected into 293 TREX to 440 
generate the adenovirus, as previously described (Stanton et al., 2008).    441 
HCMV infections 442 
For proteomic analysis, 24h prior to each infection 1.5 x 107 HFFs were plated in 443 
a 150cm2 flask. Cells were sequentially infected at multiplicity of infection 10 444 
with HCMV strain Merlin. >90% of cells were routinely infected using this 445 
approach as assessed by MHC I down-regulation. Infections were staggered such 446 
that all flasks were harvested simultaneously. For NK cell degranulation, flow 447 
cytometry and western blot analyses, cells were seeded in growth medium at 448 
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appropriate cell densities (1x106 cells for a 25cm2 flask). The following day, the 449 
cells were infected with virus at the required multiplicity of infection in an 450 
appropriate volume of growth medium (2 ml for a 25cm2 flask) for 2 h on a 451 
rocker at 37°C in 5% CO2. The innoculum was then replaced with fresh growth 452 
medium (7 ml for a 25cm2 flask), and the cells were incubated for the required 453 
times. Fetal calf serum was omitted from the growth medium for mock and 454 
HCMV infections. For inhibitor studies, cells were treated 12 h prior to 455 
harvesting with lysosomal inhibitors (leupeptin 200µM, Merck Millipore Cat. no. 456 
108975) in DMEM. For siRNA experiments, cells were seeded in a 25cm2 flask at 457 
8x105 cells/flask 24h prior to transfection and then transfected in Optimem 458 
medium (Invitrogen) with 120pmol B7-H6 (SI04761351, 459 
Hs_DKFZp686O24166_5, Qiagen) or control siRNA (AllStar Negative Control 460 
siRNA, 1027281, Qiagen) using Lipofectamine RNAiMax (Invitrogen) for a 461 
further 24h before infection with HCMV (MOI 20) in serum free DMEM for a 462 
further 72h.  463 
Adenovirus Infections 464 
Adenovirus infections were carried out in HF-CAR (MOI 5). Cells were seeded in 465 
growth medium at appropriate cell densities (1x106 cells for a 25cm2 flask). The 466 
following day, the cells were infected with virus at the required multiplicity of 467 
infection in an appropriate volume of growth medium (2 ml for a 25cm2 flask) for 468 
2 h on a rocker at 37°C in 5% CO2. The inoculum was then replaced with fresh 469 
growth medium (7 ml for a 25cm2 flask), and the cells were incubated for the 470 
required times. 471 
Protein isolation, peptide labeling with tandem mass tags 472 
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Preparation of PM and WCL protein and peptide samples was performed as 473 
described previously (Weekes et al., 2014). For PM analysis, 100% of each 474 
tryptic peptide sample was labeled with TMT reagent, and 6 fractions generated 475 
from combined peptide samples by tip-based strong cation exchange. For WCL 476 
analysis, cells were lysed in 6M Guanidine / 50mM HEPES pH8.5 then processed 477 
as described (Weekes et al., 2014). Proteins were digested with LysC then 478 
Trypsin. Peptides were labeled with TMT reagent, and 12 fractions generated by 479 
high pH reversed phase HPLC. 480 
Mass spectrometry and data analysis 481 
Mass spectrometry and data analysis were performed as described previously 482 
(Weekes et al., 2014). Briefly, we performed mass spectrometry using an 483 
Orbitrap Fusion, and quantified TMT reporter ions from the MS3 scan (McAlister 484 
et al., 2012, Ting et al., 2011). Peptides were identified and quantified using a 485 
Sequest-based in-house software pipeline. A combined database was searched, 486 
consisting of: (a) human Uniprot, (b) Merlin strain HCMV Uniprot and (c) all 487 
additional novel HCMV ORFs (Stern-Ginossar et al., 2012). Peptides spectral 488 
matches (PSM) were filtered to a 1% peptide false discovery rate (FDR) using 489 
linear discriminant analysis (Huttlin et al., 2010). The resulting dataset was 490 
further collapsed to a final protein-level FDR of 1%. Protein assembly was guided 491 
by principles of parsimony. Where all PSM from a given HCMV protein could be 492 
explained either by a canonical gene or novel ORF, the canonical gene was picked 493 
in preference. Proteins were quantified by summing TMT reporter ion counts 494 
across all matching PSM after filtering based on isolation specificity (Pease et al., 495 
2013). Reverse and contaminant proteins were removed, and protein 496 
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quantitation values were exported for normalization and further analysis in 497 
Excel. Where all PSMs from a given HCMV protein could be explained either by a 498 
canonical gene or novel ORF, the canonical gene was picked in preference. For 499 
five viral proteins that had related novel ORFs (N-terminal extensions of the viral 500 
protein), some peptides could either have originated either from the canonical 501 
protein or the novel ORF. In these cases, each of the novel ORFs were quantified 502 
based only on unique peptides that could only have originated from that ORF. 503 
Peptides that could either have originated from the canonical protein or the 504 
novel ORF were assigned to the canonical protein. We estimated p values for the 505 
ratios of each mutant compared to HCMV Merlin or leupeptin-treated cells 506 
infected with HCMV Merlin to HCMV Merlin-infected cells, using Benjamini-507 
Hochberg corrected Significance B values (Cox and Mann, 2008). Hierarchical 508 
clustering was performed using centroid linkage with Pearson correlation. The 509 
Database for Annotation, Visualization and Integrated Discovery (DAVID, 510 
RRID:SCR_001881) was used to determine protein family enrichment amongst 511 
KEGG pathways (Huang da et al., 2009). A given cluster was always searched 512 
against a background of all proteins quantified within the relevant experiment.  513 
Flow cytometric analysis of cell surface marker expression 514 
Flow cytometry was performed as described previously (Fielding et al., 2014), 515 
except HF-TERTs were harvested using HyQtase (Thermofisher) for 3 min at 516 
37°C, instead of Trypsin/EDTA. The following phycoerytherin (PE)-conjugated 517 
antibodies were used at the indicated dilutions (200µl per stain): anti-518 
CD166/ALCAM (Biolegend, Clone 3A6, Cat. no. 343904, 1:80, 519 
RRID:AB_2289302), anti-EPHA2 (Biolegend, Clone SHM16, Cat. no. 356804, 1:80, 520 
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RRID:AB_2561807), anti-CD323/JAM3 (Biolegend, Clone SHM33, Cat. no. 521 
356704, 1:80, RRID:AB_2561802), anti-CD130/IL6ST (Biolegend, Clone 2E1B02, 522 
Cat. no. 362003, 1:80, RRID:AB_2563401), IgG1 isotype (Biolegend, Clone MOPC-523 
21, Cat. no. 400112, 1:80, RRID:AB_326434), mouse IgG2a isotype (Biolegend, 524 
Clone MOPC-173, Cat. no. 400212, 1:160, RRID:AB_326460) and mouse IgG2b 525 
isotype (Biolegend, Clone MPC-11, Cat. no. 400314, 1:80, RRID:AB_326492). The 526 
following unconjugated antibodies were used at the indicated dilutions (200µl 527 
per stain):  anti-CXADR/CAR (Merck Millipore, Cat no. 05-644, Clone RmcB, 528 
1:500, RRID:AB_309871), anti-CD266/TWEAK R/TNFRSF12A (Biolegend, Clone 529 
ITEM-4, Cat. no. 314102, 1:200, RRID:AB_2240752), anti-MICA (BAMOMAB, Cat. 530 
no.  AM01, 1:400, RRID:AB_2636811), anti-MICB (BAMOMAB, Cat. no. BM02, 531 
1:400, RRID:AB_2636812), anti-B7-H6 (Biotechne R&D Systems, Clone 875001, 532 
Cat. no. MAB7144, 500µg/ml, 1:50, RRID:AB_2636810), anti-MHC I (AbD Serotec, 533 
Clone W6/32, MCA81EL, 1:1,000, RRID:AB_324063) and mouse IgG (Santa Cruz 534 
Biotechnology, Cat. no. Sc-2025, 400µg/ml, 1:40, RRID:AB_737182 or Sigma, Cat. 535 
no. I-5381 1mg/ml, 1:100, RRID:AB_1163670), followed by an Alexa Fluor 647 536 
goat anti-mouse IgG secondary antibody (Thermo Fisher Scientific, Cat. no. 537 
A21237, 1:500, RRID:AB_2535806).  538 
Immunoblotting 539 
Whole cell lysates were prepared in 1x Nupage gel sample buffer (Thermo Fisher 540 
Scientific) plus 10mM DTT and samples were denatured at 95°C or 50°C (US18 541 
and US20 adenovirus experiment) for 10mins. SDS-PAGE and subsequent 542 
immunoblotting was carried out as previously described either using X-ray film 543 
or the Syngene G:Box Chemix-xx6 GeneSys system to visualise the blots (Fielding 544 
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et al., 2014).  Membranes were probed with antibodies directed against B7-H6 545 
(non-commercial CH31 monoclonal, purified at 2µg/ml final or hybridoma 546 
supernatant 1:5), anti-V5 antibody (AbD Serotec, Cat. no. MCA1360, 1:2000, 547 
RRID:AB_322378) and actin (Sigma, Cat. no A2066, 1:5000, RRID:AB_476693), 548 
followed by HRP-conjugated goat anti-mouse or anti-rabbit antibodies (BioRad, 549 
Cat. no. 170-6516, RRID:AB_11125547 and 170-6515, RRID:AB_11125142 550 
respectively, both 1:5000). 551 
NK degranulation assays 552 
NK degranulation assays were performed as described previously using anti-553 
CD107a-FITC (Cat. no. 555800, BD Biosciences, RRID:AB_396134) or isotype 554 
control-FITC (Cat no. 555748, BD Biosciences, RRID:AB_396090) and anti-CD3-555 
PE-Cy7 (Cat. no. 737657, Beckman Coulter, RRID:AB_2636813) and anti-CD56-556 
PE (Cat. no. A07788, Beckman Coulter, RRID:AB_2636814) antibodies and PBMC 557 
derived from buffy coats or donor blood, except that infected HF-TERTs were 558 
harvested using HyQtase for 3 min at 37°C, instead of Trypsin/EDTA 559 
(Prod'homme et al., 2007, Prod'homme et al., 2010, Fielding et al., 2014). 560 
Blocking experiments were performed as previously described except using B7-561 
H6 blocking antibody (CH31) or isotype IgG1 control antibody at 10µg/ml 562 
(Biolegend, Cat. no. 401404, Clone MG1-45, RRID:AB_345426 or Biolegend Cat 563 
no. 401402 Clone MG1-45, RRID:AB_345424) (Fielding et al., 2014). 564 
NKp30 reporter assays 565 
HF-TERTs were seeded into 96-well plates and either mock-infected or infected 566 
with HCMV or US12 family deletion mutants (MOI 10) for 72h. The CT299 567 
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reporter line (2B4 cells stably transfected with an NFAT-GFP reporter and 568 
NKp30) was washed in complete RPMI and 50,000 reporter cells added per well 569 
(5:1 ratio of reporter to target cells).  In some experiments,  the B7-H6 blocking 570 
antibody (CH31) or isotype IgG1 control antibody (Biolegend, Cat. no. 401404, 571 
Clone MG1-45, RRID:AB_345426 or Biolegend Cat no. 401402 Clone MG1-45, 572 
RRID:AB_345424)  at 10µg/ml were also added to the wells. After 24h 573 
incubation, reporters were harvested, washed in FACS buffer and fixed with 2% 574 
paraformaldehyde before analysis by flow cytometry. 575 
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 824 
Figure legends 825 
Figure 1. Multiple US12 family proteins regulate NK activation 826 
A. Fibroblasts (HF-TERTs) were mock infected or infected with the Merlin strain 827 
of HCMV or the series of US12 family deletion mutants for 72h. Infected cells 828 
were incubated with donor PBMC for 5h and NK degranulation assessed by % 829 
CD107+ cells within the CD3-, CD56+ population by flow cytometry. B. CD107 830 
assay results (mean and SD) are shown from 4 separate donors performed in 831 
duplicate or triplicate and analysed by unpaired ordinary one way ANOVA with 832 
Dunnett’s test for multiple comparisons against the HCMV control  *p<0.05, 833 
**p<0.01, ***p<0.005 ***p<0.001). Infected cells were assessed by the % cells 834 
with down-regulated MHC I compared to the mock-infected cells (for the 835 
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experiment using  donor #23 and # 385, HCMV 93%, ΔUS12 94%, ΔUS13 98%, 836 
ΔUS14 94%, ΔUS15 98%, ΔUS16 99%, ΔUS17 98%, ΔUS18 97%, ΔUS19 99%, 837 
ΔUS20 97%, ΔUS21 91%, ΔUS12-21 94%; for the experiment using  donor #91 838 
and # 285, HCMV 94%, ΔUS12 94%, ΔUS13 94%, ΔUS14 83%, ΔUS15 95%, 839 
ΔUS16 97%, ΔUS17 85%, ΔUS18 94%, ΔUS19 96%, ΔUS20 94%, ΔUS21 94%, 840 
ΔUS12-21 96%).  841 
Figure 2. The US12 family targets numerous plasma membrane proteins 842 
Cells infected with HCMV (Merlin) or HCMV ΔUS12-21 mutant were processed to 843 
give PM or WCL fractions and analyzed by TMT mass spectrometry. Scatter plot 844 
of proteins identified in the PM (panel A) or WCL fractions (panel B) respectively 845 
and quantified by 2 or more unique peptides. Fold change (ΔUS12-21-infected 846 
fibroblasts/HCMV-infected cells) is shown as the log2 ratio on the x-axis and the 847 
signal:noise on the y-axis as log10.  Proteins unaltered by the US21-21 deletion 848 
locate at the center of the plots (0 log2/1 fold-change), whereas proteins to the 849 
left or right of center represent proteins down- or up-regulated by the US12-21 850 
deletion respectively. Significance B was used to estimate p values (Cox et al., 851 
2009). The 2 different alleles of MICA present in HFs were detected by this 852 
analysis.  853 
Figure 3. Hierarchical cluster analysis of all proteins quantified in 854 
proteomic series 1 and 2. 855 
Zoomed regions are shown for clusters of interest.   856 
Figure 4. Proteomic analysis of cellular proteins targeted by US12 family 857 
members in PM samples 858 
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A-B Workflows of proteomic series 1 and 2 respectively. C-E. Quantitation of PM 859 
proteins in enriched KEGG pathways identified using DAVID. Relative abundance 860 
of each protein is expressed relative to the sample with the highest abundance 861 
(set to 1). NQ – not quantified. A number of the US12-21 mutant targets were 862 
also regulated by the US18 and US20 mutants (B7-H6, ULBP2, IL6ST, KIT, KITLG 863 
JAM3, ACVR1, ACVRL1, IFNGR1, JAM3, MPZL1, CXADR, ALCAM, SDC4, CD99, 864 
SDC1). A subset of these proteins were also regulated by the US14 and/or US16 865 
mutants (KIT, KITLG, ACVR1, IFNGR1, JAM3, MPZL1, CD99, SDC1). We estimated 866 
p values for the ratios of each mutant compared to HCMV Merlin using 867 
Benjamini-Hochberg corrected Significance B values (Cox and Mann, 2008): * 868 
p<0.05, ** p<0.0001. For proteomic series 1, ratios were calculated as US12 869 
family deletion mutant / average HCMV and for proteomic series 2, US12 family 870 
deletion mutant / HCMV. All proteins quantified by 2 or more peptides were 871 
included in this calculation. SDC1 was quantified by a single peptide in proteomic 872 
series 2. 873 
Figure 5. Individual US12-family proteins target key natural killer cell 874 
ligands, cell adhesion molecules and cytokines and their receptors in WCL 875 
samples. 876 
A-C. Quantitation of key US12 family targets in WCL samples (proteomic series 1 877 
and 2 - comparative analysis of these proteins from PM samples is shown in 878 
Figure 3). We generally observed similar results for proteins quantified in both 879 
PM and WCL samples. Relative abundance of each protein is expressed relative 880 
to the sample with the highest abundance (set to 1). NQ – not quantified. P values 881 
were calculated as described in Figure 4: * p<0.05, ** p<0.0001. MICB was only 882 
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quantified by 1 peptide in proteomic series 1, and MICA, JAM3 and SDC4 by one 883 
peptide in proteomic series 2. 884 
Figure 6. Co-regulation of multiple cell surface proteins by >1 US12 family 885 
gene 886 
Proteins that were rescued by deletion of each US12 family member in the PM 887 
fraction of proteomic Series 2 (i.e. not including US19) were analyzed to 888 
determine which were additionally targeted by one or more US12 family 889 
members. Proteins were plotted in a matrix with unique protein targets on the 890 
lower diagonal of the plot (US12 family member compared with itself) and 891 
common protein targets in intersections with other US12 members.  To identify 892 
the highest confidence targets of the US12-21 family for the purposes of this 893 
analysis and to generate a shortlist of US12-21 family PM ‘hits’, we employed the 894 
following strategy: we included proteins (a) exhibiting at least 3-fold rescue 895 
upon deletion of a given US12 family member, quantified by at least two peptides 896 
and annotated by GO to indicate a PM location. (b) validated by a corresponding 897 
>2-fold change in at least one of (i) deletion of the US12-21 block (proteomic 898 
series 1 or 3), (ii) the biological repeat of US18 or US20 in proteomic series 1, 899 
(iii) the corresponding gene deletion in WCL proteomic series 2. This strategy 900 
identified all proteins shown in Figure 3. *US19 data was used from proteomic 901 
series 1. 902 
Figure 7. Altered expression of US20, UL32 and UL99 levels in the US21 903 
deletion mutant-infected fibroblasts. 904 
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 Quantitation of US20, UL32 and UL99 in proteomic series 1-3 in both PM and 905 
WCL. Abundance of each protein is expressed relative to the sample with the 906 
highest abundance (set to 1). For proteomic series 1 and 2, p values were 907 
calculated as described in Figure 4: * p<0.05, ** p<0.0001. US20 was only 908 
quantified by 1 peptide in proteomic series 1, WCL experiment.  909 
Figure 8. Multiple US12 gene family targets are degraded via the lysosomal 910 
pathway 911 
A. Workflow of Proteomic Series 3. B. Number of proteins targeted by the US12-912 
21 block and additionally rescued> 2-fold in the dataset by the ΔUS12-21 913 
deletion mutant or rescued >2-fold or >1.5-fold by leupeptin treatment for both 914 
WCL and PM. C. Comparable degree of rescue of US12-21 target proteins by 915 
US12-21 deletion and leupeptin treatment. Quantitation of a subset of these 916 
proteins is shown relative to the maximum abundance (set to 1). p-values were 917 
calculated as described in Figure 4, for the ratios of leupeptin treatment or US12-918 
21 deletion virus infection at each time point compared to the matched wild-type 919 
Merlin-infected control. * p<0.05, ** p<0.0001. SDC1 was only quantified by 1 920 
peptide.  921 
Figure 9. Regulation of UL16 levels by the US12 family. 922 
Quantitation of UL16 in proteomic series 1-3 in both PM and WCL. Relative 923 
abundance of each protein is expressed relative to the sample with the highest 924 
abundance (set to 1). For proteomic series 1 and 2, p values were calculated as 925 
described in Figure 4: * p<0.05, ** p<0.0001. 926 
Figure 10. Validation of cell surface proteins regulated by the US12 family  927 
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Flow cytometry confirmed proteomic data for proteins representative of each 928 
category enriched in the DAVID analysis. Staining in mock/US12 family member 929 
deletion mutant infections (blue line) is shown relative to the parental HCMV 930 
infection (red line). Flow cytometry was carried out for cell surface expression of 931 
MHC I (W6/32) as a control for HCMC infection and isotype antibody staining 932 
controls (with directly PE-conjugated IgG1, IgG2a or IgG2b antibodies or for 933 
unconjugated antibodies mIgG and an anti-mouse-AF647 conjugated secondary 934 
antibody). Infected cells were assessed by the % cells with down-regulated MHC 935 
I compared to the mock-infected cells (HCMV 94%, ΔUS12 94%, ΔUS13 94%, 936 
ΔUS14 83%, ΔUS15 95%, ΔUS16 97%, ΔUS17 85%, ΔUS18 94%, ΔUS19 96%, 937 
ΔUS20 94%, ΔUS21 94%, ΔUS12-21 96%). Results are representative of at least 938 
two independent experiments. 939 
Figure 11.Adenovirus expressed B7-H6 regulates NK cell activation and B7-940 
H6 levels are regulated by ectopically-expressed US18 and US20. 941 
A. HF-CARs were infected with control (RAd-CTRL) or B7-H6-expressing (RAd-942 
B7-H6) adenovirus vectors (MOI 5). Cells were harvested 48h p.i. and used as 943 
targets in a CD107 degranulation assay with buffy-coat derived PBMC from 3 944 
separate donors in duplicate or triplicate. Results (shown as mean and SD) were 945 
analyzed by unpaired two-tailed Student’s T-test. ***p<0.001, ****p<0.0001. B 946 
and C. HF-CARs were infected with control (RAd-CTRL) or B7-H6-expressing 947 
(RAd-B7-H6) adenovirus vectors (MOI 5). Cells were harvested 48h p.i. and B7-948 
H6 cell surface expression analyzed by flow cytometry (B) or western blot (C). 949 
Results are representative of at least 2 independent experiments. D.  HF-CARs 950 
were infected with adenovirus control (CTRL), US18-expressing adenovirus, 951 
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US20-expressing adenovirus or a combination of both US18 and US20 (MOI 5 952 
each, made up to a total MOI of 10 with RAd-CTRL). After 24h incubation, HF-953 
CARs were infected with adenovirus control (CTRL) or B7-H6-expressing 954 
adenovirus (B7-H6) at MOI 5 as indicated before incubation for a further 48h. 955 
Whole cell lysates were prepared and analysed by immunoblotting with the 956 
antibodies indicated. Results are representative of two independent 957 
experiments. 958 
Figure 12. Differences in B7-H6 levels on HCMV US12 family deletion 959 
mutant-infected cells regulate NKp30-mediated responses 960 
A. Whole cell lysates were prepared from mock, HCMV or the series of US12 961 
family deletion mutant infected fibroblasts and analyzed by immunoblotting 962 
with antibodies specific for B7-H6 (CH31) or actin. Results are representative of 963 
two independent experiments.  B. An NKp30-responsive 2B4 reporter cell line 964 
containing a NFAT-GFP reporter construct (CT299) was incubated for 24h with 965 
mock, HCMV or the series of US12 family deletion mutant infected fibroblasts in 966 
triplicate. Fixed cells were then analyzed for GFP fluorescence by flow cytometry 967 
compared to cells incubated with no target fibroblasts. Results are expressed as 968 
the % GFP positive reporter cells (mean and SD) and were analyzed by unpaired 969 
two-tailed Student’s T-test. Results are representative of two independent 970 
experiments. C. HF-TERTs were transfected with control (C) or B7-H6 (B7) 971 
siRNAs for 24h prior to infection with the parent HCMV, ΔUS18, ΔUS20 or 972 
ΔUS12-21 mutants for 72hrs. Cells were then incubated for 24h with CT299 973 
NKp30 reporter cells in triplicate and GFP+ cells determined by flow cytometry, 974 
and analysed by unpaired two-tailed Student’s t-test. Results (mean and SD) are 975 
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representative of two independent experiments.  D. HF-TERTs infected with 976 
HCMV, ΔUS18, ΔUS20 or ΔUS12-21 mutants were incubated for 24h with CT299 977 
NKp30 reporter cells, in the presence isotype control (C) or B7-H6 blocking 978 
antibodies (B7) in triplicate, GFP+ cells determined by flow cytometry and 979 
analyzed by unpaired two-tailed Student’s t-test. Results (mean and SD) are 980 
representative of two independent experiments.   981 
Figure 13. B7-H6 regulation has a major effect on NK activation in response 982 
to HCMV infection 983 
A & B. HF-TERTs were transfected with control (C) or B7-H6 (B7) siRNAs for 24h 984 
prior to infection with the parent HCMV, ΔUS18, ΔUS20 or ΔUS12-21 mutants. 985 
Cells were harvested 72h p.i. and B7-H6 cell surface expression analyzed by flow 986 
cytometry (E) or used as targets in a CD107 degranulation assay with donor-987 
derived PBMC in triplicate (F). Results (mean and SD) were analyzed by 988 
unpaired two-tailed Student’s t-test and are representative of two independent 989 
experiments using 2 separate donors in each. Infected cells were assessed by the 990 
% cells with down-regulated MHC I compared to the mock-infected cells (HCMV 991 
CTRL siRNA 95%, ΔUS18 CTRL siRNA 91%, ΔUS20 CTRL siRNA 93%, ΔUS12-21 992 
CTRL siRNA 86%, HCMV B7-H6 siRNA 96%, ΔUS18 B7-H6 siRNA 84 %, ΔUS20 993 
B7-H6 siRNA 96%, ΔUS12-21 B7-H6 siRNA 79%). C. HF-TERTs infected with 994 
HCMV, ΔUS18, ΔUS20 or ΔUS12-21 mutants were used as targets in a CD107 995 
degranulation assay with donor-derived PBMC, in the presence isotype control 996 
(C) or B7-H6 (B7) blocking antibodies in triplicate. Results (mean and SD) were 997 
analyzed by unpaired two-tailed Student’s t-test and are shown for two separate 998 
donors. * p<0.05, ** p<0.01, ***p<0.001, **** p<0.0001.  999 
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 1000 
Table 1. HCMV constructs used in the study  1001 
Virus BAC # Accession no. Cassette used Modification Previous 
reference 
HCMV 1111 GU179001.1 None RL13-, UL128- Stanton et al.,
2010 
ΔUS12 1810 KU221097 GalK US12 CDS deleted 
 
None
ΔUS13 1831 KU221099 GalK US13 CDS deleted 
 
None
ΔUS14 1798 KU221093 GalK US14 CDS deleted 
 
None
ΔUS15 1800 KU221094 GalK US15 CDS deleted 
 
None
ΔUS16 1802 KU221095 GalK US16 CDS deleted 
 
None
ΔUS17 1804 KU221096 GalK US17 CDS deleted 
 
None
ΔUS18 1654 KU221091 RpsL-Neo-LacZ US18 CDS deleted Fielding et al., 
2014 
ΔUS19 1796 KU221092 RpsL-Neo-LacZ US19 CDS deleted 
 
None
ΔUS20 1595 KU221090 SacB-AmpR-LacZ US20 CDS deleted Fielding et al., 
2014 
ΔUS21 1871 KU221100 RpsL-Neo-LacZ US21 CDS deleted 
 
None
ΔUS12-21 1815 KU221098 RpsL-Neo-LacZ US12-21 deleted 
 
None
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Table 2. Primers used in the construction of the HCMV US12 deletion 1002 
mutants library  1003 
Primer Sequence (5’>3’) 
US12 GalK For GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTCCTGTTGACAATTAATCATCGGCA 
US12 GalK Rev  AAACTTGCCGGGTACCTGAAGCCCCGACGACTGTTCGTCGAGCACCCG TCTCAGCACTGTCCTGCTCCTT 
US12 Delete  GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTGACGGGTGCTCGACGAACAGTCGTCGGGGCTTCAGGTAC
US13 GalK For  CTTCAGGTACCCGGCAAGTTTTATAGAGAAAGGGGGACGATGGGTGGTGGCCTGTTGACAATTAATCATCGGCA 
US13 GalK Rev  GAAGACTCCACCGAGACGCTCACCCGTTCACTCGGGCGCATCACCCGC CTTCAGCACTGTCCTGCTCCTT 
US13 Delete  CTTCAGGTACCCGGCAAGTTTTATAGAGAAAGGGGGACGATGGGTGGTGGAGGCGGGTGATGCGCCCGAGTGAACGGGTGAGCGTCTC
US14 GalK For  GAGTGAACGGGTGAGCGTCTCGGTGGAGTCTTCTTATAAACCAGCGGG TCCCTGTTGACAATTAATCATCGGCA 
US14 GalK Rev  CTGTAGCTTCGAGACCTTGCGGATACGCCGCCGGGCGCTGCGGTCCCG ACTCAGCACTGTCCTGCTCCTT 
US14 Delete  GAGTGAACGGGTGAGCGTCTCGGTGGAGTCTTCTTATAAACCAGCGGGTCGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCT
US15 GalK For  CTCCATGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCTCGAAGCCTGTTGACAATTAATCATCGGCA 
US15 GalK Rev  CGGAACTGGTTTTCGGACAGAGCAGCCGTTTCCAGAGAACGCAGCGCA CCTCAGCACTGTCCTGCTCCTT 
US15 Delete  CTCCATGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCTCGAAGGGTGCGCTGCGTTCTCTGGAAACGGCTGCTCTGTCCGAA
US16 GalK For  CGTTCTCTGGAAACGGCTGCTCTGTCCGAAAACCAGTTCCGAACGAAAATCCTGTTGACAATTAATCATCGGCA 
US16 GalK Rev  CCCCACGGATCTCGCGTCTTAGACGCGCGGTCATATAGCCTCCGGCTG TCTCAGCACTGTCCTGCTCCTT 
US16 Delete  CGTTCTCTGGAAACGGCTGCTCTGTCCGAAAACCAGTTCCGAACGAAAATGACAGCCGGAGGCTATATGACCGCGCGTCTAAGACGCGAG
US17 GalK For  TTGGTGGAGACGGCCGGCGCGGCGGGTGGGGGAAACGACGAGTTTTTCCGCCTGTTGACAATTAATCATCGGCA 
US17 GalK Rev  ACACTCTATAAACGGTTTCTCATACGCGCCTTTTGATAGCCACCGCCG TCTCAGCACTGTCCTGCTCCTT 
US17 Delete  TTGGTGGAGACGGCCGGCGCGGCGGGTGGGGGAAACGACGAGTTTTTCCGGACGGCGGTGGCTATCAAAAGGCGCGTATGAGAAACC
US19 SacB For  CAGCACCCGGTTACCGCGGATTTGATTGACGTCACGAGTGTGGTCAAACCGTGGCGGCACCCTGTATCCGACCCGTCGCCTGTGACGGAA
US19 SacB Rev  GCTACGCCTCTATGTCGAAAATGTGGCTTTATTCATCGGCATGTACCATCTTCTGAGGCTCTGGTTGTGGAGCCCATGACTGAGGTTCTTAT
US19 Delete  ACGTCACGAGTGTGGTCAAACCGTGGCGGCACCCTGTATCCGACCCGTCGGGCGACAAGCGCGGCTGCTGTGAAAACGGGCGCGGTTTT
US21 SacB For  TGCGGCGCACCTACCCTTCTCTTATACACAAGCGAGCGAGTGGGGCACGGTGACGTGGTCACGCCGCGGACACGTCGACCTGTGACGGA
US21 SacB Rev  CAGCGCCCACACTGCTCAGACGACGGTCGCTGCGACGGTCGCTGCCACAGCAGCGGCGTCGCCCCAGTTCGTCTCCTAACTGAGGTTCTT
US21 Delete CAAGCGAGCGAGTGGGGCACGGTGACGTGGTCACGCCGCGGACACGTCGAGGCGGCAACGCCGGCGGTTATCGCCGAGATTCGTCTAA
US12-21 Delete GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTGGCGGCAACGCCGGCGGTTATCGCCGAGATTCGTCTAAA
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 1004 
Table 3. Primers used in the local sequencing of the HCMV US12 deletion 1005 
mutant library 1006 
Primer Sequence (5’>3’)
US12 Seq For  CCCTGTCTAGACTCAAAAGCTG 
US12 Seq Rev  ATCGTCCCCCTTTCTCTATA 
US13 Seq For  GCCGAGTGGCTCGCC 
US13 Seq Rev  CTGGGCACCTATCATCATTA 
US14 Seq For  GGAGGGAAGCCCATTGC 
US14 Seq Rev  TCATTACCTGTCTAGCCG 
US15 Seq For  CGGACGCGGCTTCC 
US15 Seq Rev  GTCGCTACAGCTCTTTATTA 
US16 Seq For  GGGGCACGTAGATGACCG 
US16 Seq Rev  CTCATTAGACAAACTCATCG 
US17 Seq For  GTCTAAGACGCGAGATCCG 
US17 Seq Rev  CCCAGTAGACAGACAGAACA 
US19 Seq For  GGAGCGGCACGATGGTGACC 
US19 Seq Rev  TCTGCCCACCTAACCAATGC 
US21 Seq For  GCTGAAAGATGAAGATGGCG 
US21 Seq Rev  ACCCGACCAGATGGGAGACG 
 1007 
 1008 
Supplemental File 1. Interactive spreadsheet of all US12 family proteomic 1009 
data (separate Excel Spreadsheet). 1010 
This spreadsheet enables the generation of graphs showing the relative 1011 
expression of any of the human and HCMV proteins quantified across Proteomic 1012 
series 1-3 in PM and WCL fractions by typing the gene name into the indicated 1013 
box. The datasets used to generate the graph and protein aliases are present in 1014 
the other tabs. 1015 
 1016 
 1017 
 1018 
 1019 













